Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
18 studies found for:    Open Studies | "Supranuclear Palsy, Progressive"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Supranuclear Palsy, Progressive"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Young Plasma Transfusions for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Other: Fresh Frozen Plasma
2 Recruiting A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: F-18 AV 1451
3 Recruiting A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Intervention: Drug: Salsalate
4 Recruiting Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy (PSP)
Interventions: Drug: Rivastigmine;   Drug: Placebo
5 Recruiting Foot Mechanical Stimulation for Treatment of Gait and Gait Related Disorders in Parkinson's Disease and Progressive Supranuclear Palsy.
Conditions: Idiopathic Parkinson's Disease;   Progressive Supranuclear Palsy
Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
6 Recruiting PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Conditions: Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
Intervention:
7 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
Interventions: Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
8 Recruiting Study of the Neural Basis of Analogical Reasoning
Conditions: Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
Interventions: Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
9 Recruiting Biomarkers in Parkinsonian Syndromes
Conditions: Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
Interventions: Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
10 Recruiting Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
Conditions: Alzheimer's Disease (AD);   Progressive Supranuclear Palsy (PSP);   Cortical Basal Syndrome (CBS);   Frontal Temporal Dementia (FTD)
Intervention: Drug: [18F]MNI-815 (MNI-815)
11 Recruiting Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Vascular Parkinsonism
Intervention: Other: MRI exam of the brain
12 Recruiting Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Conditions: Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
Intervention:
13 Recruiting 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Conditions: Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Intervention: Other: Observational Study
14 Recruiting Diagnosing Frontotemporal Lobar Degeneration
Conditions: Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
Intervention: Other: Observational Study
15 Recruiting Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Conditions: Alzheimer's Disease (AD);   Parkinson's Disease (PD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
Intervention: Drug: [18F]T807 ([18F]MNI-777)
16 Not yet recruiting Unique Brainstem Biomarkers of Early Parkinson's Disease
Conditions: Parkinson's Disease;   Alzheimer's Disease;   Progressive Supranuclear Palsy;   Essential Tremor;   Multiple System Atrophy;   Drug Induced Parkinson's Disease;   Diffuse Lewy Body Disease;   Myasthenia Gravis
Interventions: Other: Electrical Brainstem Responses;   Other: Olfactory Tests;   Other: Visual Deprivation
17 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
18 Not yet recruiting Vaccination Uptake (VAX) in PD
Condition: Parkinson's Disease
Interventions: Behavioral: Standard of Care;   Behavioral: Home Visit Program (HVP)

Study has passed its completion date and status has not been verified in more than two years.